A 75-year-old patient should be offered a statin for primary prevention - Discussion.
Session:
Controversies in Cardiovascular Disease Prevention: Statin for Primary Prevention at Age 75
Topic:
Risk Factors and Prevention
Congress Presentation
2 more presentations in this session
Access the full session
About the event
ESC CONGRESS 2020 - The Digital Experience
28 August - 1 September 2020
Congress
Related content
ESC Premium Access
Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial
27 August 2021
ESC Premium Access
The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients
27 August 2021
ESC Premium Access
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
27 August 2021
ESC 365 is supported by
